No Data
No Data
SonoScape Medical Corp. (SZSE:300633) Adds CN¥666m in Market Cap and Insiders Have a 56% Stake in That Gain
Key Insights Insiders appear to have a vested interest in SonoScape Medical's growth, as seen by their sizeable ownership The top 4 shareholders own 53% of the company 27% of SonoScape Medical is
Nomura Adjusts Sonoscape Medical's Price Target to 49.97 Yuan From 55.47 Yuan, Keeps at Buy
03:34 AM EDT, 04/29/2024 (MT Newswires) -- Nomura Adjusts Sonoscape Medical's Price Target to 49.97 Yuan From 55.47 Yuan, Keeps at Buy Price (RMB): ¥41.46, Change: ¥+0.27, Percent Change: +0.66%
Kaili Healthcare (300633.SZ) announced first-quarter results, net profit of 100 million yuan, a decrease of 27.65%
According to the Zhitong Finance App, Kaili Healthcare (300633.SZ) released its report for the first quarter of 2024. The company's revenue was 479 million yuan, an increase of 1.33% over the previous year. Net profit attributable to shareholders of listed companies was 100 million yuan, a year-on-year decrease of 27.65%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 92.22,900 yuan, a year-on-year decrease of 26.55%. Basic earnings per share were $0.2326.
Open Healthcare (300633.SZ): Net profit for 2023 increased by 22.88% to 454 million yuan, and plans to pay 10 to 3.2 yuan
On April 11, Gelonghui Healthcare (300633.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 2.120 billion yuan, an increase of 20.29%; net profit attributable to shareholders of listed companies was 454 million yuan, up 22.88% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 442 million yuan, an increase of 29.52% year on year; basic income per share was 1.06 yuan; it plans to distribute a cash dividend of 3.2 yuan (tax included) to all shareholders for every 10 shares.
Is There An Opportunity With SonoScape Medical Corp.'s (SZSE:300633) 48% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, SonoScape Medical fair value estimate is CN¥67.53 SonoScape Medical's CN¥35.38 share price signals that it might be 48% undervalued The CN
Risks To Shareholder Returns Are Elevated At These Prices For SonoScape Medical Corp. (SZSE:300633)
With a price-to-earnings (or "P/E") ratio of 40.1x SonoScape Medical Corp. (SZSE:300633) may be sending bearish signals at the moment, given that almost half of all companies in China have P/E ratios
No Data